FOXM1 and hepatocellular carcinoma: Moreover, our data suggested strong inhibition of HCC cell migration and invasion (Figure 4) in Artemisinin-treated cells following FoxM1 silencing, foreboding the promising anti-metastatic prospect of Artemisinin.